We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+34.19%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$180B
AUM Growth
+$34.5B
Cap. Flow
+$124M
Cap. Flow %
0.07%
Top 10 Hldgs %
43.41%
Holding
443
New
192
Increased
135
Reduced
77
Closed
14

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$1.73B
2
ONC
BeOne Medicines Ltd
ONC
+$774M
3
ILMN icon
Illumina
ILMN
+$691M
4
DXCM icon
DexCom
DXCM
+$438M
5
NFLX icon
Netflix
NFLX
+$360M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 37.71%
2 Technology 16.18%
3 Healthcare 15.43%
4 Communication Services 14.41%
5 Financials 5.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMRX icon
426
Amneal Pharmaceuticals
AMRX
$5.79B
$2K ﹤0.01%
+517
New +$2.29K
ICPT
427
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2K ﹤0.01%
+86
New +$2.85K
TRUE
428
DELISTED
TrueCar
TRUE
$1K ﹤0.01%
+351
New +$1.56K
CLVS
429
DELISTED
Clovis Oncology, Inc.
CLVS
$1K ﹤0.01%
+142
New +$718
AXP icon
430
American Express
AXP
$230B
-141,786
Closed -$14.2M
CIB icon
431
Grupo Cibest SA
CIB
$21.1B
-257,155
Closed -$6.57M
DNOW icon
432
DNOW Inc
DNOW
$2.99B
-100,000
Closed -$454K
KEX icon
433
Kirby Corp
KEX
$6.93B
-3,192,941
Closed -$115M
XPEV icon
434
XPeng
XPEV
$11.6B
-80,110
Closed -$1.61M
ORTX
435
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
-274,000
Closed -$11.3M
VAR
436
DELISTED
Varian Medical Systems, Inc.
VAR
-65,009
Closed -$11.2M
MYOK
437
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-20,993
Closed -$2.86M
BITA
438
DELISTED
Bitauto Holdings Limited
BITA
-16,750
Closed -$264K
LVGO
439
DELISTED
Livongo Health, Inc. Common Stock
LVGO
-16,542
Closed -$2.32M
AMTD
440
DELISTED
TD Ameritrade Holding Corp
AMTD
-6,746,337
Closed -$264M
ATVI
441
DELISTED
Activision Blizzard
ATVI
-161,314
Closed -$13.1M

Similar funds

Baillie Gifford & Co's Q4 2020 Portfolio in Review

As of Q4 2020, Baillie Gifford & Co held 443 positions worth $180B, up 24% from $145B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Baillie Gifford & Co's Q4 2020 filing shows 192 new, 135 increased, 77 reduced and 14 closed positions. Its largest new stake was Kingsoft Cloud Holdings: 7,346,496 shares worth $320M. The largest sale was Tesla, an estimated $3.79B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, up from 37% a quarter earlier, followed by Technology and Healthcare.

  • Baillie Gifford & Co's largest Q4 2020 buy was Kingsoft Cloud Holdings: 7,346,496 shares worth $320M.
  • Baillie Gifford & Co added most to Moderna in Q4 2020, an estimated $1.73B increase.
  • Baillie Gifford & Co's biggest Q4 2020 reduction was Tesla, cutting an estimated $3.79B.
  • Baillie Gifford & Co fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $264M.
  • Baillie Gifford & Co's ten largest holdings make up 43% of its $180B portfolio in Q4 2020.
  • Baillie Gifford & Co opened 192 new positions and closed 14 in Q4 2020.
  • Baillie Gifford & Co's portfolio value rose 24% quarter-over-quarter to $180B.

Based on Baillie Gifford & Co's 13F filing for Q4 2020, filed 10 Feb 2021.